Abstract:Background: Growth factor receptor-bound protein 2 (Grb2) is a 25 kDa adaptor protein, which was originally discovered to accomplish basic cellular events such as cell growth, cell proliferation, and metabolism. However, recent studies evidenced that Grb2 was largely involved in multiple tumor malignancies. The mature Grb2 is a 217 amino acid sequence, which consists of one Src homology 2 (SH2) domain flanked by two Src homology 3 (SH3) domains. Using these binding motives, the ubiquitously expressed Grb2 acts as an intermediate between cell-surface activated receptors and downstream targets. Objectives: Consequently, the Grb2 becomes the key element of this oncogenesis and launched a number of defected signaling cascades. Therefore, vast concern of the Grb2 in multiple cancer patterns makes it an attractive therapeutic target. In this review, we have compiled the maximum tumor conformations caused by the involvement of the Grb2, the central role of Grb2 in numerous oncogenic pathways and particular approaches that can be useful to downregulate the Grb2 overexpression. We will discuss in details the activity of different types of novel peptides, their high affinity for the Grb2 protein and blockade of Grb2 mediated signaling pathways by targeting the SH2/SH3 binding sites. Methods & Results: There is a three-fold aspect to this review: Grb2 protein introduction, Grb2 protein involvement in cancer, and the role of peptides as Grb2 antagonists. First, Grb2 and compiled maximum tumor conformations induced by Grb2 involvement were introduced. Secondly, several oncogenic pathways of Grb2 involvement and particular approaches potentially useful to downregulate Grb2 overexpression were outlined. The activity of different types of novel peptides for the Grb2 protein was also detailed. Last but not least, the blockade of Grb2-mediated signaling pathways by targeting SH2/ SH3 binding sites were summarized. Conclusion: We have epitomized the utmost cancer malignancies caused by abnormal signaling of the Grb2 adaptor molecule. Indeed, Grb2's enormous involvement in the progression and development of different cancers broaden our tactics to build anticancer drug candidates. Depending on the high affinity and increased specificity we have described the major potent peptides which may efficiently target and block the SH2 or SH3 arms of the Grb2. It may be of benefit for developing novel anticancer peptides. However, further work is needed to pinpoint more binding motives of Grb2 to generate efficacious anticancer agents for diverse human cancers in the near future.

The Configuration of GRB2 in Protein Interaction and Signal Transduction

GRB2: A dynamic adaptor protein orchestrating cellular signaling in health and disease

The role of Grb2 in cancer and peptides as Grb2 antagonists.

Different molecular recognition by three domains of the full-length GRB2 to SOS1 proline-rich motifs and EGFR phosphorylated sites

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Growth-Factor Receptor-Bound Protein-2 (Grb2) Signaling In B Cells Controls Lymphoid Follicle Organization And Germinal Center Reaction

GRB2 is a BECN1 interacting protein that regulates autophagy

The Function Study on the Interaction Between Grb2 and AMPK.

Ligand-Based Structural Optimization of Grb2-SH2 Inhibitors: High Affinity, Low Charge and Reduced Peptidic Nature

Grb2 Phosphorylation Antagonizes EGFR-driven Ras Activation by Interfering with Condensate Assembly

A Non-Canonical Function of Gβ As a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation.

The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia

Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase

The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling

Gab2 Signaling in Breast Cancer

Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation

Double life: How GRK2 and β-arrestin signaling participate in diseases

Targeting Grb2 SH3 Domains with Affimer Proteins Provides Novel Insights into Ras Signalling Modulation

G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions and inflammation